David R. Repaske, MD, PhD

David R. Repaske, PhD, MD is chief of the Section of Endocrinology at Nationwide Children’s Hospital and Director of the Division of Endocrinology and Metabolism in the Department of Pediatrics at The Ohio State University based at Nationwide Children’s Hospital. Dr. Repaske is board certified in Pediatric Endocrinology. He received his PhD from the University of Wisconsin-Madison in Biochemistry and his medical degree from Vanderbilt University School of Medicine. He did his residency at the University of North Carolina at Chapel Hill. He has completed fellowships in Human Genetics at Vanderbilt and Pediatric Endocrinology at Chapel Hill. He is an advisor on a National Committee of the American Diabetes Association.

His clinical research interests include the molecular basis of inherited diabetes insipidus, optimal therapy for congenital adrenal hyperplasia, and innovations in care for diabetes and other chronic conditions.

Gender:

• Male

Languages Spoken:

• English

Medical School

• Vanderbilt University School of Medicine
  Date Completed: 05/10/1985

Fellowship

• Vanderbilt University School of Medicine
  Date Completed: 05/31/1986

Residency

• University of North Carolina at Chapel Hill Hospi
  Date Completed: 06/30/1988

Residency

• University of North Carolina at Chapel Hill Hospi
  Date Completed: 12/31/1988

Fellowship

• University of North Carolina at Chapel Hill Hospi
  Date Completed: 12/31/1991

Department:

• Pediatrics

Section:

• Endocrinology/Metabolism/Diabetes

Speciality:

• Pediatric Endocrinology, Certified
  
• Pediatrics
  

Date of Appointment at Children's Hospital:

• 04/24/2009

• Ingerski LM, Laffel L, Dortar D, Repaske DR, Hood KK. 2010. Correlates of Glycemic Control and Quality of Life Outcomes in Adolescents with Type 1 Diabetes.  Pediatric Diabetes. Vol. 11, no. 8. (December): 563-571. doi: 10.1111/j.1399-5448.2010.00645.x.
• Cortina S, Repaske DR, Hood KK. 2010. Sociodemographic and psychosocial factors associated with continuous subcutaneous insulin infusion in youth with type 1 diabetes.  Pediatric Diabetes. Vol. 11. (August): 337-344.
• Gutmark-Little, I, Repaske, DR, and Backeljauw, PF. 2010. Efficacy and Safety of Intranasal Desmopressin Acetate Administered Orally for the Management of Infants with Neurogenic Diabetes Insipidus (DI) [Abstract]. 92nd Annual Endocrine Society Meeting. San Diego. (June) (Published)
• Dye, AS, Atkin, JF, Anglin, K, Repaske, DR, Hardin, DS. 2010. Protocol for Early Introduction of Growth Hormone Therapy in Prader Willi Syndrome Yields Good Clinical Results [Abstract]. 92nd Annual Endocrine Society Meeting. San Diego. (June) (Published)
• Repaske DR. 2010. Review of Thesis, Inorganic Ions in Bacterial Chemotaxis: Roles of H+, Mg++, Ca++, and Membrane Potential Changes: University of Wisconsin, Madison, 1980 (Published)
• Ingerski LM, Vesco A, Laffel L, Repaske DR, Anderson BJ, Hood KK. 2009. Trends in blood glucose monitoring and A1c in adolescence; contribution of conflict and responsibility [Abstract]. American Diabetes Assocation, 69th Scientific Sessions, New Orleans, LA. (June) (Published)
• McGrady ME; Laffel L; Drotar D; Repaske D; Hood KK. 2009. Depressive symptoms and glycemic control in adolescents with type 1 diabetes: mediational role of blood glucose monitoring.  Diabetes Care. Vol. 32, no. 5. (May 1): 804.
• Repaske, D.R. 2009. Disorders of Water Balance. In Brook's Clinical Pediatric Endocrinology. 6th ed. Edited by Brook, C., Clayton, P., Brown, R. Chichester, West Sussex, UK: Wiley-Blackwell. 343-373.
• Morwessel NJ, Campbell LL, Repaske DR. 2008. Building Support for Ongoing Parental Participation in Diabets Self-Management [Abstract]. Abstract, National Association of Children's Hospitals and Related Institutions 2008 Annual Meeting, Salt Lake City, UT. (October) (Published)
• 2008. Review of Making the transition from pediatric to adult endocrinology services., by Repaske DR; Handwerger S. (September 01): 492. (Published)
• Repaske, DR and Handwerger, S. 2008. Making the Trnasition from Pediatric to Adult Endocrinology.  Nature Clinical Practice Endocrinology and Metabolism. Vol. 4. : 492-493. doi:10.1038/ncpendmet0890.
• Repaske, D.R. 2008. Congenital Adrenal Hyperplasia. In The 5-Minute Obstetrics and Gynecology Clinical Consult. Edited by Hillard, P.J. Philadelphia, PA, USA: Wolters Kluwer/Lippincott Williams & Wilkins. 88-89.
• Siuciak JA; McCarthy SA; Chapin DS; Reed TM; Vorhees CV; Repaske DR. 2007. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme.  Neuropharmacology. Vol. 53, no. 1. (July 1): 113.
• Repaske DR, Haury SD, Dimuzio T, Campbell LL, Allen SR and the Self-Management Group of the Diabets Pursuing Perfection Team. 2005. Reading from the Same Page Promotes Consistency and Self-Management in Pediatric Diabetes [Abstract]. Abstract, National Association of Children's Hospitals and Related Institutions 2005 Annual Meeting, Indian Wells, CA. (October) (Published)
• Repaske DR, Haury SD, Dimuzio T, Campbell LL, Allen SR and the Self-Management Group of the Diabetes Pursuing Perfection Team. 2005. Reading from the Same Page Promotes Consistency and Self-Management in Pediatric Diabetes [Abstract]. Abstract, European Society for Pediatric Endocrinology/Lawson Wilkins Pediatric Endocrin Society Joint Meeting, Lyon, France. (September) (Published)
• Repaske DR, Campbell LL, Allen SR, Dimuzio T, Atherton HD, Dolan LM and the Diabets Pursuing Perfection team. 2005. Improving Hemoglobin A1c in an Academic Pediatric Diabetes Center: What Have We Done, and Who has Responded? [Abstract]. Abstract, American Diabetes Associations 65thScientific Sessions, San Diego, CA. (June) (Published)
• Repaske DR, Campbell LL, Allen Sr, Dimuzio T, Atherton HD, Dolan LM and the Diabetse Pursuing Perfection Team. 2005. Improving Hemoglobin A1c in an Academic Pediatric Diabetes Center: What Have We Done, and Who Has Responded? [Abstract]. Abstract, American Diabetes Assocation 65th Scientific Session, San Diego, CA. (June) (Published)
• Repaske DR, Dolan LM, Campbell LL, Allen SR and the Diabetes Pursuing Perfection Team. 2004. New Onset Type 1a Diabetes Therapy: Family Choice Of NPH/R vs. Basal/Bolus Therapy (BBT) Matters [Abstract]. Abstract, Pediatric Academic Societies 2004 Annual Meeting, San Francisco, May (Published)
• Repaske DR, Campbell L, Hatcher L, Taylor J, Dimuzio T, Morewessell NJ, Allen SR, Dolan LM and the Diabetes Pursuing Perfection Team. 2004. Offering Choice of HPH/Reg or Basal Bolus Insulting Therapy for Children with New Onset Diabetes Mellitus [Abstract]. Abstract, American Diabetes Association 64th Scientific Sessions, Orlando, FL, June (Published)
• Repaske DR, Allen SR, Campbell LL, Hatcher L, Taylor JL, DiMuzio T, Morwessell NJ, Dolan LM and the Diabetes Pursuing Perfection Team. 2004. Family Choice of Insulin Therapy Improves Diabetes Control [Abstract]. Abstract, National Association of Children's Hospitals and Related Institutions 2004 Annual Meeting, Ft Lauderdale, FL, Oct (Published)
• Van Staveren WC; Steinbusch HW; Markerink-Van Ittersum M; Repaske DR; Goy MF; Kotera J; Omori K; Beavo JA; De Vente J. 2003. mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain.  The Journal Of Comparative Neurology. Vol. 467, no. 4. (December 22): 566.
• Browning JE, Coolen LM, Repaske DR. 2003. Distribution of PDE1B Protein in Mouse Brain: Consistent with a Role in Suppressing Dopamine Signaling [Abstract]. Abstract, Cincinnati Translational Neuroscience Symposium, March (Published)
• Santiprabhob J; Browning J; Repaske D. 2002. A missense mutation encoding Cys73Phe in neurophysin II is associated with autosomal dominant neurohypophyseal diabetes insipidus.  Molecular Genetics And Metabolism. Vol. 77, no. 1-2. (September 1): 112.
• Reed TM; Repaske DR; Snyder GL; Greengard P; Vorhees CV. 2002. Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning.  The Journal Of Neuroscience: The Official Journal Of The Society For Neuroscience. Vol. 22, no. 12. (June 15): 5188.
• McCarthy SA, Chapin DS, Fujiwara, RA, Repaske DR and Siuciak JA. 2002. Behavioral Charterization of PDE1B Knockout Mice [Abstract]. Abastract 263.4, Society for Neuroscience Annual Meeting, Orlando, FL, Nov (Published)
• Santiprabhob JS, Browning JE and Repaske DR. 2002. Identification of a novel missense mutation in the coding sequence for neurophysin II (Cys73Phe) associated with autosomal dominant neurohypophyseal diabetes insipidus [Abstract]. Abstract P3-604, Endocrine Society 84th Annual Meeting, San Francisco, June (Published)
• Santiprabhob JS, Chernausek SD, Rose SR, Reitz RE, Fisher DA and Repaske DR. 2002. Falsely elevated serum thyroid-stimulating hormone (TSH) in a newborn infant due to maternal TSH autoantibody [Abstract]. Abstract P1-593, Endocrine Society 84th Annual Meeting, San Francisco, CA June (Published)
• Wong, SK-F, Fidock MD, Repaske DR, Shrikhande AV and Ryan AM. 2002. PDE1B is a brain-specific and striatal-encriched cyclic nucleotide phosphodiesterase [Abstract]. Abstract, Society for Neuroscience Annual Meeting, Orlando, Nov (Published)
• Zhang YH; Huang BL; Anyane-Yeboa K; Carvalho JA; Clemons RD; Cole T; De Figueiredo BC; Lubinsky M; Metzger DL; Quadrelli R; Repaske DR; Reyno S; Seaver LH; Vaglio A; Van Vliet G; McCabe LL; McCabe ER; Phelan JK. 2001. Nine novel mutations in NR0B1 (DAX1) causing adrenal hypoplasia congenita.  Human Mutation. Vol. 18, no. 6. (December 1): 547.
• King JL; Naber JM; Hopkin RJ; Repaske DR; Bailey L; Leslie ND. 2001. Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia.  Archives Of Pediatrics & Adolescent Medicine. Vol. 155, no. 9. (September 1): 1038.
• Chapin DS, Repaske DR, Reed TM, Vorhees CV and Siuciak JA. 2001. Dopamine and serotonin content and turnover is altered in associations with changes in locomotor activity in PDE1B knockout mice [Abstract]. Abstract, Society for Neuroscience Annual Meeting, San Diego, Oct (Published)
• Snyder GI, Reed TM, Galdi S, Greengard P, Vorhees CV and REpaske DR. 2001. Enchanced dopamine signaling in PDE1B-deficient mouse brain [Abstract]. Abstract, Society for Neuroscience annual Meeting, San Diego, Oct (Published)
• DiMeglio LA; Gagliardi PC; Browning JE; Quigley CA; Repaske DR. 2001. A missense mutation encoding cys(67) --> gly in neurophysin ii is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus.  Molecular Genetics And Metabolism. Vol. 72, no. 1. (January 1): 39.
• Santiprabhob J, Smith EP, McCabe ERB and Repaske DR. 2000. Late onset of adrenal insufficiency in adrenal hypoplasia congenita caused by a frameshift mutation of the DAX-1 gene [Abstract]. Abstract 2596 Endocrine Society 82nd Annual Meeting, Toronto, Ontario, June (Published)
• Reed TM, Repaske DR and Vorhee CV. 2000. Phosphodiesterase 1 B-deficient mice demonstrate hyperactivity and learning deficits [Abstract]. Abstract NBTS-49, Neurobehavioral tetatology Society 24th Annual Meeting, Palm Beach, FL, June (Published)
• Repaske, D.R. 1999. Molecular Basis of Inherited forms of Diabetes Insipidus. In Molecular and Cellular Basis of Pediatric Endocrinology. Contemporary Endocrinology, P. Michael Conn, ed. Edited by Handwerger, S. Totowa, NJ, USA: Humana Press. 153-177.
• Arunchaiya S, Srivuthana K, Browning JE, Steinbrecher K and Repaske DR. 1999. Cellular toxicity caused by mutations in the vasopressin gene in inherited neurohypophyseal diabetes insipidus [Abstract]. Abstract P3-599, Endocrine Society 81st Annual Meeting, San Diego, June (Published)
• Reed TM; Browning JE; Blough RI; Vorhees CV; Repaske DR. 1998. Genomic structure and chromosome location of the murine PDE1B phosphodiesterase gene.  Mammalian Genome: Official Journal Of The International Mammalian Genome Society. Vol. 9, no. 7. (July 1): 571.
• Reed TR, Qiang W, Vorhees CV, Repaske DR. 1998. Creation and characterization of the PDE1B knockout mouse [Abstract]. Gordon Research Conference on Cyclic Nucleotide Phosphodiesterases, New London, NH, June 12-14 (Published)
• Qiang W and Repaske DR. 1998. Biochemical and deletion mutataion characterization of PDE1B [Abstract]. Gordon Research Conference on Cyclic Nucleotide Phosphodiesterases, New London, NH, June 12-14 (Published)
• Gagliardi PC; Bernasconi S; Repaske DR. 1997. Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23-->Val in neurophysin II.  The Journal Of Clinical Endocrinology And Metabolism. Vol. 82, no. 11. (November 1): 3643.
• Reed TM, Browning JE, Blough RI, Vorhees CV, Repasek DR. 1997. Characterization of genomic structure of the murine 63 kDa calmodulin-dependent phosphodiesterase [Abstract]. Abstract, Rachford Symposium. Cincinnati. (September) (Published)
• Repaske DR; Medlej R; Gültekin EK; Krishnamani MR; Halaby G; Findling JW; Phillips JA 3rd. 1997. Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1-->Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor.  The Journal Of Clinical Endocrinology And Metabolism. Vol. 82, no. 1. (January 1): 51.
• Reed TM, Browning JE, Blough RI, Vorhees CV and Repaske DR. 1997. Characterization of the genomic structure of the murine 63 kDa calmodulin-dependent phosphodiesterase [Abstract]. Abstract, Society for Neuroscience Annual Meeting, New Orleans, Oct (Published)
• Srivuthana K, Gultekin EK, Browning JE and Repaske DR. 1997. Misprocessing of Preprovasopressin in Autosomal Dominant Neurohypophyseal Diabetes Insipidus [Abstract]. Endocrine Society Annual Meeting Abstract P1-482, June (Published)
• Goy, M.F., Li, Z., Zimmermann, E.M. and Repaske, D.R. 1996. In situ hybridization as a tool to identify neurons that express downstream components of the cyclic GMP cascade. Review of In situ hybridization as a tool to identify neurons that express downstream components of the cyclic GMP cascade. Methods Neurosci. Vol. 31. (September): 80-111. [Editor Reviewed] (Published)
• Repaske DR; Summar ML; Krishnamani MR; Gültekin EK; Arriazu MC; Roubicek ME; Blanco M; Isaac GB; Phillips JA 3rd. 1996. Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus.  The Journal Of Clinical Endocrinology And Metabolism. Vol. 81, no. 6. (June 1): 2328.
• Goy, MF, Li, Z, Zimmermann, EM, and Repaske, DR. 1996. In situ hybridization as a tool to identify neurons that express downstream components of the cyclic GMP cascade.  Methods in Neuroscience. Vol. 31. : 80-111.
• Gagliardi PC, Bernasconi S, Quigley CA and Repaske DR. 1996. Molecular Analysis of autosomal dominant neurohypophyseal diabetes insipidus [Abstract]. Abstract P3-812, 10th International Congress of Endocrinology, San Francisco, June (Published)
• Gagliardi PC, Bernasconi S, Quigley CA and Repaske DR. 1995. Molecular Analysis of autosomal doinant neurohypophyseal diabetes insipidus [Abstract]. Abstract P3812, 10th International Congress of Endocrinology, San Francisco, June (Published)
• Reed TR, Browning JE, Vorhees CV and Repaske DR. 1995. Characterization of the Murine 63 kDa calmodulin-dependent phosphodiesterase gene [Abstract]. 42nd Rachford Lectures Symposium on Transcriptional Control of Embryogenesis (Published)
• Repaske DR, Conti M, Brar AK and Goy MF. 1995. Multiple mammalian homologs of the Drosophila dunce cAMP-specific phosphodiesterase memory gene are differently expressed in rat brain [Abstract]. 25th Steenbeck Symposium on Behavior and Signaling in Microorganisms, Madison WI (Published)
• Gultekin EK, Findling JW, Borwning JE and Repaske DR. 1995. Diabetes insipidus resulting from a signal peptide mutation in the arginine wasopressin-neurophysin II gene [Abstract]. Pediatric Research. Vol. 37: A90. (Published)
• Yang Q; Paskind M; Bolger G; Thompson WJ; Repaske DR; Cutler LS; Epstein PM. 1994. A novel cyclic GMP stimulated phosphodiesterase from rat brain.  Biochemical And Biophysical Research Communications. Vol. 205, no. 3. (December 30): 1850.
• Repaske DR; Browning JE. 1994. A de novo mutation in the coding sequence for neurophysin-II (Pro24-->Leu) is associated with onset and transmission of autosomal dominant neurohypophyseal diabetes insipidus.  The Journal Of Clinical Endocrinology And Metabolism. Vol. 79, no. 2. (August 1): 421.
• Repaske, DR, Phillips JA III, Krishnamani MRS, Gultekin E, Arriazu MC and Roubicek M. 1994. Recurring dominant-negative mutations in the AVP-NPII gene cause neurohypophyseal diabetes insipidus [Abstract]. Am J Hum Genetics. Vol. 55: A239. (Published)
• Repaske DR, Conti M, Barar AK and Goy MF. 1994. Multiple mammalian homologs of the Drosophila dunce cAMP-specific phosphodiesterase memory gene are differentially expressed in rat brain [Abstract]. The Endocrine Society, Abstract #1757, 75th Annual Meeting, Anaheim CA (Published)
• Repaske DR; Corbin JG; Conti M; Goy MF. 1993. A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain.  Neuroscience. Vol. 56, no. 3. (October 1): 673.
• Repaske DR and Browning JE. 1993. Characterization of the Molecular Defect in the Vasopressin-Neurophysin II Gene in a Family with Autosomal Dominatn Neurohypophyseal Diabetes Insipidus [Abstract]. Pediatric Research. Vol. 33: S29. (Published)
• Repaske DR; Swinnen JV; Jin SL; Van Wyk JJ; Conti M. 1992. A polymerase chain reaction strategy to identify and clone cyclic nucleotide phosphodiesterase cDNAs. Molecular cloning of the cDNA encoding the 63-kDa calmodulin-dependent phosphodiesterase.  The Journal Of Biological Chemistry. Vol. 267, no. 26. (September 15): 18683.
• Repaske DR. 1992. Localization of Expression of Rat Brain cGMP-stimulated Cyclic Nucleotide Phosphodiesterase [Abstract]. 8th International Conference on Second Messengers and Phosphoproteins (Published)
• 1992. Review of The molecular biology of human hereditary central diabetes insipidus., by Repaske DR; Phillips JA 3rd. (January 01): 295. (Published)
• Corbin JG, Repaske DR, Contin M and Goy MF. 1992. Localization of cGMP-stimulated Phosphodiesterase mRNA in Rat Brain [Abstract]. Soc Neurosci. Vol. 18 Part 1: 105. (Published)
• Repaske, DR and Phillips, JA III. 1992. The Molecular Biology of Human hereditary Central Diabetes Insipidus. In Progress in Brain Research. Vol. 93. Edited by Swaab, DR, Hofman, MA, Mirmiran, M, Ravid, R, nad van Leeuwen, FW. Amsterdam: Elsevier. 295-308.
• 1991. Review of Hormonal regulation of cyclic nucleotide phosphodiesterases., by Conti M; Jin SL; Monaco L; Repaske DR; Swinnen JV. (August 01): 218. (Published)
• Thompson WJ, Scammell JG, Strada SJ, Henzel W and Repaske DR. 1991. Identification of Type II (Cyclic GMP-Stimulatable) Cyclic Nucleotide Phosphodiesterase (CNPDE) mRNA in Rat Pheochromocytoma Cells (PC 12) [Abstract]. FASEB Journal. Vol. 5: A1592. (Published)
• Repaske DR. 1991. Molecular Cloning of a Novel Cyclic Nucleotide Phosphodiesterase (PED) from a Mouse Lymphoma Cell Line with Increased Activity of a Cyclic GMP-Inhibited PDE [Abstract]. The Endocrine Society (Published)
• Conti, M, Jin, S-LC, Monaco, L, Repaske, DR, Swinnen, JV. 1991. Hormonal Regulation of Cyclic Nucleotide Phosphodiesterases.  Endocrine Reviews. Vol. 12. : 218-234.
• Repaske DR; Phillips JA 3rd; Kirby LT; Tze WJ; D'Ercole AJ; Battey J. 1990. Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus.  The Journal Of Clinical Endocrinology And Metabolism. Vol. 70, no. 3. (March 1): 752.
• Repaske DR, Swinnen JV and Conti M. 1990. Cloning a Carboxy-Terminal Domain of the Rat cGMP-Stimulated Phosphodiesterase by Polymerase Chain Reaction [Abstract]. The Endocrine Society (Published)
• 1987. Review of Application of molecular genetics to pediatric gynecology., by Repaske DR; Phillips JA 3rd. (September 01): 762. (Published)
• Repaske, DR and Phillips, JA III. 1987. Application of Molecular Genetics to Pediatric Gynecology.  Clinical Obstetrics and Gynecology. Vol. 30. : 762-775.
• Butler MG; Repaske DR; Joseph GM; Phillips JA 3rd. 1987. High resolution chromosome and DNA analysis in multiple endocrine neoplasia type II syndrome.  Cancer Genetics And Cytogenetics. Vol. 24, no. 1. (January 1): 129.
• 1986. Review of Molecular analysis of familial human growth hormone disorders., by Repaske DR; Phillips JA 3rd. (March 01): 114. (Published)
• Repaske, DR and Phillips, JA III. 1986. Molecular Analysis of Familial Human Growth Hormone Disorders.  BioEssays. Vol. 4. : 114-118.
• Repaske DR, Phillips JA III, Kirby LT, Tze WJ, D'Ercole, AJ and Battey J. 1986. DNA Analysis of Autosomal Dominant Neurohypophyseal Diabetes Insipidus [Abstract]. Clinical Research. Vol. 34: 646A. (Published)
• Phillips JA III, Repaske DR, Kirby LT, Tze J and Battery J. 1986. Genetic Analysis of Autosomal Dominant Neurohypophyseal Diabetes insipidus [Abstract]. Am J Hum Genet. Vol. 39: A215. (Published)
• Repaske DR; Garbers DL. 1983. A hydrogen ion flux mediates stimulation of respiratory activity by speract in sea urchin spermatozoa.  The Journal Of Biological Chemistry. Vol. 258, no. 10. (May 25): 6025.
• Repaske DR; Adler J. 1981. Change in intracellular pH of Escherichia coli mediates the chemotactic response to certain attractants and repellents.  Journal Of Bacteriology. Vol. 145, no. 3. (March 1): 1196.
• Repaske, DR. 1980. Inorganic Ions in Bacterial chemotaxis: Roles of H+, Mg++, Ca++, and Membrane Potential Changes. Madison, Wisconsin: University of Wisconsin.